InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by VIERLING JOHN, Director. Insider active across 1 company, notably Athenex, Inc.. In total, 8 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €2k. History available since 7 May 2021. The latest transaction was disclosed on 21 April 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
6,513 shares@ US$1.30518.3% of flowCommon StockSEC:0001209191-23-025413:0
45,701 shares@ US$0.18618.5% of flowCommon StockSEC:0001209191-23-003406:0
35,284 shares@ US$0.240920.5% of flowCommon StockSEC:0001209191-22-053423:0
7,500 sharesCommon StockSEC:0001209191-22-048061:0
12,772 shares@ US$0.665519.7% of flowCommon StockSEC:0001209191-22-042882:0
11,303 shares@ US$0.75280.8% of flowCommon StockSEC:0001209191-22-024054:0
250 shares@ US$4.509.6% of flowCommon StockSEC:0001209191-21-031230
Ideal exit: 1 Feb 2022 (T+270)
250 shares@ US$4.509.6% of flowCommon StockSEC:0001209191-21-031230:0
Ideal exit: 1 Feb 2022 (T+270)
8 of 8 declarations
About VIERLING JOHN
VIERLING JOHN is a Board Member of Athenex, Inc. He brings expertise in biopharmaceuticals to the board, helping to guide the company's strategy and support its market development.
